Q3 2015

Source filing unavailable

Q3 2015 · —

Revenue—

Net Income

-$30.96M

N/M vs Q3 2014

EPS Diluted

-$0.50

N/M vs Q3 2014

Operating Income-$30,245,000N/M

Operating Cash Flowderived-$24,030,000N/M

Free Cash Flowderived

Same quarter

Metric	Q3 2015	Q3 2014	Q3 2013	Q3 2012
Revenue	—	—	—	$0.00
Net Income	-$30.96M	-$23.99M	-$17.33M	-$9.38M
EPS Diluted	-$0.50	-$0.54	-$0.46	-$0.38

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

INSMED Inc · CIK 1104506 · Engraved from SEC EDGAR